Tranylcypromine Sulfate
2 NDCs across 2 manufacturers|2 Generic,0 Brand
Tranylcypromine Sulfate is used to treat depressive disorder and post-traumatic stress disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 16, 1985, and the first generic was approved Jun 29, 2006. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $3 million on Tranylcypromine Sulfate across 12,000 claims for 1,842 beneficiaries.
Tranylcypromine Sulfate is available as 2 NDCs from 2 manufacturers (2 generic, 0 brand), with NADAC prices from $0.59 to $0.59 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
2
competing in market
Price Spread
$0.59 – $0.59
per EA
7d Activity
avg +2.8% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Actavis Pharma, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Monoamine Oxidase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing TRANYLCYPROMINE SULFATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TRANYLCYPROMINE SULF 10 MG TAB | $0.5911 per EA | +2.77% |
TRANYLCYPROMINE SULF 10 MG TAB | $0.5911 per EA | +2.77% |
Frequently Asked Questions
What is Tranylcypromine Sulfate used to treat?
Tranylcypromine Sulfate is used to treat depressive disorder and post-traumatic stress disorders, per the National Library of Medicine's MED-RT classification.
When did Tranylcypromine Sulfate become available as a generic?
FDA approved the first generic Tranylcypromine Sulfate (ANDA) on Jun 29, 2006. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Tranylcypromine Sulfate?
In 2024, Medicare Part D spent $3 million on Tranylcypromine Sulfate across 12,000 claims for 1,842 beneficiaries.
How many Tranylcypromine Sulfate products are on the market?
The Tranylcypromine Sulfate drug market contains 2 NDCs from 2 manufacturers — 2 generic and 0 brand products.
What is the price range for Tranylcypromine Sulfate?
NADAC reference prices for Tranylcypromine Sulfate range from $0.5911 to $0.5911 per EA.
Which manufacturers make Tranylcypromine Sulfate?
2 manufacturers list Tranylcypromine Sulfate in NADAC. Ranked by number of NDCs, the largest are Actavis Pharma, Inc. (1), Strides Pharma Inc. (1).
How has the price of Tranylcypromine Sulfate changed recently?
Over the past 7 days, 2 Tranylcypromine Sulfate NDCs rose and 0 fell, with a market-wide average change of +2.8%.